Literature DB >> 26142409

Is it time to revise linezolid doses in peritoneal dialysis patients? A case series.

Cristina Gervasoni1, Roberto Bergia2, Valeria Cozzi3, Emilio Clementi4, Dario Cattaneo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26142409     DOI： 10.1093/jac/dkv184

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients.

Authors:  Hitoshi Kawasuji; Yasuhiro Tsuji; Chika Ogami; Makito Kaneda; Yushi Murai; Kou Kimoto; Akitoshi Ueno; Yuki Miyajima; Yasutaka Fukui; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Antibiotics (Basel)       Date:  2021-04-26

2.  Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.

Authors:  Terry King-Wing Ma; Chi Bon Leung; Kai Ming Chow; Bonnie Ching-Ha Kwan; Philip Kam-Tao Li; Cheuk Chun Szeto
Journal:  Clin Kidney J       Date:  2016-07-04

Review 3.  Peritoneal dialysis-related peritonitis: challenges and solutions.

Authors:  William L Salzer
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.